Bond, a US-based technology investment firm established by Silicon Valley stalwart Mary Meeker, has led a AUD 60m (USD 43m) Series C round for Australian telehealth platform Eucalyptus.
BGH Capital has set the hard cap for its second Australia and New Zealand-focused fund at AUD 3.5bn (USD 2.5bn), having reached a first close of approximately AUD 3bn.
CapVest Partners, a UK-headquartered private equity firm that primarily invests in Europe and North America, has entered the race for Australian fertility care business Virtus Health with an AUD 650.1m (USD 469m) offer.
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
Quadrant Private Equity has sold Journey Beyond, an Australia-based experiential tourism business, to US-based Hornblower Group, which is best known for offering cruise and sightseeing packages.
A rebound in China-based activity took Asia private equity investment to a record USD 105.3bn in the fourth quarter, ensuring that 2021 represents a new high watermark for the industry.
Australia turnaround investor Allegro Funds has appointed Fay Bou as its third partner, serving alongside co-founders Adrian Loader and Chester Moynihan.
Five Elms Capital, a specialist growth investor in software start-ups globally, has led a USD 32m Series B round for New Zealand and US-based customer feedback platform AskNicely.
Pioneer Capital, New Zealand Superannuation Fund, and Comprador Holdings have together acquired a 70% stake in Fertility Associates, a New Zealand-based fertility treatment provider.
Pacific Equity Partners (PEP) has agreed on exits from two energy infrastructure-related businesses, taking the Australia-based private equity firm to four announced liquidity events within a fortnight.
Australia’s Blackbird Ventures has led a $25 million Series B round for Inventia Life Science, a local start-up that provides 3D cell cultures for research and clinical purposes.
Tiger Global Management has led a $325 million Series E round for Australia-based e-commerce marketing technology provider Rokt.
BGH Capital has submitted a take-private bid for Virtus Health, an Australia-based fertility care services provider, that values the business at approximately A$607.3 million ($432 million).
Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
Pacific Equity Partners (PEP) has agreed two healthcare exits, with Australia-based medical devices distributor LifeHealthcare to be sold to Ebos Group and New Zealand corporate hospital platform Evolution Healthcare going to QIC and Sunsuper.
Ontario Teachers’ Pension Plan (OTPP) has made an investment of undisclosed size in KKR-backed GreenCollar, an environmental services provider that helped establish Australia’s carbon credit market.
Finder, an Australian financial technology start-up with a diversified suite of retail investor services, has raised A$30 million ($21.5 million) from local VC firm Future Now Capital.
Singapore-based Aura Private Equity has acquired a majority stake in Australian Vaccine Services (AVS), a leading provider of corporate flu vaccinations.
Sponsor-to-sponsor exits are set to reach a record high in Asia this year as private equity firms increase velocity of deployment and some strategics remain in a pandemic-induced funk
Goldman Sachs Asset Management has committed A$137 million ($96 million) to Synergis, an Australian investment platform focused on providing housing for people with disabilities.
Fortitude Investment Partners, an Australia-based private equity firm established by professionals from Blue Sky Alternative Investments, has backed cosmetic medical business Aura Medical Group.
Horizons Ventures, the private investment arm of Hong Kong billionaire Li Ka-Shing, has led a A$129 million ($92.3 million) Series B round for Australia’s Harrison.ai, a clinical artificial intelligence (AI) developer.
Airbus Ventures has led a $25 million Series B round for Australia’s Q-Ctrl, a quantum computing developer increasingly geared toward space tech and orbital infrastructure.